EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Antimicrobial Potential of a Novel Phage-Derived Lytic Protein Against Pseudomonas aeruginosa

Sibongile Mtimka, Kanyane Bridgett Malatji, Patrick Opare Sakyi iD, Noel David Nogbou iD, Andrew Munyalo Musyoki iD, Sipho Mamputha iD, Lusisizwe Kwezi, Samuel Kojo Kwofie iD, Ofentse Jacob Pooe iD, Tsepo Lebiletsa Tsekoa iD

Current Issues in Molecular Biology · 17.03.2026 · 48 (3) · 318

DOI: 10.3390/cimb48030318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 17.03.2026. Verfasst von Sibongile Mtimka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chemicals Cluster, Council for Scientific and Industrial Research (CSIR), Pretoria 0001, South Africa. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Council for Scientific and Industrial Research (CSIR)—Department of Science and Innovation (DSI) Inter-bursary, DSI Bioinnovations—Indigenous Microbial Diversi…, CSIR Parliamentary Grant, University of Kwa-Zulu Natal Dean’s Bursary.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalation of bacterial resistance to existing antibiotics represents a growing global health challenge, exacerbated by the widespread misuse of antimicrobial agents. As a result, alternative antibacterial strategies are increasingly being explored, including phage-derived lytic proteins. In this study, we report a preliminary characterisation of a novel phage-derived lytic protein identified through computational screening of bacteriophage genome sequences. A putative open reading frame, designated SM07 (1383 bp), was selected from bacteriophage sequences contributed by the University of KwaZulu-Natal to a global phage repository. The gene was synthesised, sub-cloned into the pET-30b(+) vector with an N-terminal histidine tag, and recombinantly expressed in Escherichia coli BL-21(AI) cells. The protein was purified using affinity and ion-exchange chromatography. Purified SM07 exhibited in vitro antimicrobial activity against Pseudomonas aeruginosa, with a minimum inhibitory concentration of 4 µg/mL, while no significant cytotoxic effects were observed in Vero kidney cells at concentrations substantially above the effective dose. Together, these findings provide initial evidence supporting the antimicrobial potential of SM07 and highlight phage-derived lytic proteins as candidates for further investigation as alternative agents against P. aeruginosa-associated infections.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosaantimicrobialbacteriophage therapycatalytic domainendolysinphage-derived protein

Autor:innen und Institutionen

  • Chemicals Cluster, Council for Scientific and Industrial Research (CSIR), Pretoria 0001, South Africa.
  • Discipline of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.
  • Department of Chemical Sciences, University of Energy and Natural Resources, Sunyani P.O. Box 214, Ghana.
  • Department of Microbiology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
  • Biomedical Engineering Department, School of Engineering Sciences, University of Ghana, Legon, Accra Ga488-6615, Ghana.
  • Institute of Applied Science and Technology, University of Ghana, Legon, Accra Ga488-6615, Ghana.

ORCID-Profile: Patrick Opare Sakyi, Noel David Nogbou, Andrew Munyalo Musyoki, Sipho Mamputha, Samuel Kojo Kwofie, Ofentse Jacob Pooe, Tsepo Lebiletsa Tsekoa

Förderung

  • Council for Scientific and Industrial Research (CSIR)—Department of Science and Innovation (DSI) Inter-bursary, DSI Bioinnovations—Indigenous Microbial Diversi…
  • CSIR Parliamentary Grant, University of Kwa-Zulu Natal Dean’s Bursary

Zitieren

APA

Mtimka, S., Malatji, K. B., Sakyi, P. O., Nogbou, N. D., Musyoki, A. M., Mamputha, S., Kwezi, L., Kwofie, S. K., Pooe, O. J., & Tsekoa, T. L. (2026). Exploring the Antimicrobial Potential of a Novel Phage-Derived Lytic Protein Against Pseudomonas aeruginosa. Current Issues in Molecular Biology, 48(3), 318. https://doi.org/10.3390/cimb48030318

Vancouver

Mtimka S, Malatji KB, Sakyi PO, Nogbou ND, Musyoki AM, Mamputha S, et al. Exploring the Antimicrobial Potential of a Novel Phage-Derived Lytic Protein Against Pseudomonas aeruginosa. Current Issues in Molecular Biology. 2026;48(3):318. doi:10.3390/cimb48030318

BibTeX
@article{Mtimka2026,
  author = {Mtimka, Sibongile and Malatji, Kanyane Bridgett and Sakyi, Patrick Opare and Nogbou, Noel David and Musyoki, Andrew Munyalo and Mamputha, Sipho and Kwezi, Lusisizwe and Kwofie, Samuel Kojo and Pooe, Ofentse Jacob and Tsekoa, Tsepo Lebiletsa},
  title = {Exploring the Antimicrobial Potential of a Novel Phage-Derived Lytic Protein Against Pseudomonas aeruginosa},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {3},
  pages = {318},
  doi = {10.3390/cimb48030318}
}
Kostenlos starten →